122 related articles for article (PubMed ID: 35486221)
1. 17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicenter, Randomized Controlled Trial.
Luo C; Wei C; Guo W; Yang J; Sun Q; Wei W; Wu S; Fang S; Zeng Q; Zhao Z; Meng F; Huang X; Zhang X; Li R; Ma X; Luo C; Yang Y
Adv Ther; 2022 Jun; 39(6):2961-2970. PubMed ID: 35486221
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mastoscopic and conventional axillary lymph node dissection in breast cancer: long-term results from a randomized, multicenter trial.
Luo C; Guo W; Yang J; Sun Q; Wei W; Wu S; Fang S; Zeng Q; Zhao Z; Meng F; Huang X; Zhang X; Li R; Ma X; Luo C; Yang Y
Mayo Clin Proc; 2012 Dec; 87(12):1153-61. PubMed ID: 23146657
[TBL] [Abstract][Full Text] [Related]
3. Contrast of Mastoscopic and Conventional Axillary Lymph Node Dissection of Patients With Breast Cancer: Meta-Analysis.
Xiong H; Chen Z; Xu L; Chen C; Fu Q; Teng R; Chen J; Xie S; Wang L; Yu XF; Zhou J
Cancer Control; 2020; 27(2):1073274820932987. PubMed ID: 32602366
[TBL] [Abstract][Full Text] [Related]
4. Feasibility analysis of treating breast cancer patients with breast-conserving surgery via a periareolar incision combined with non-lipolytic suspension-type mastoscopy.
Liu J; He G; Zhang Y; Wong MP; Chu J; Kong L; Yahya MM
Sci Rep; 2023 Jul; 13(1):12129. PubMed ID: 37495629
[TBL] [Abstract][Full Text] [Related]
5. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
6. Experience of a large series of mastoscopic axillary lymph node dissection.
Chengyu L; Jian Z; Xiaoxin J; Hua L; Qi Y; Chen G
J Surg Oncol; 2008 Aug; 98(2):89-93. PubMed ID: 18484080
[TBL] [Abstract][Full Text] [Related]
7. A standardized surgical technique for mastoscopic axillary lymph node dissection.
Chengyu L; Yongqiao Z; Hua L; Xiaoxin J; Chen G; Jing L; Jian Z
Surg Laparosc Endosc Percutan Tech; 2005 Jun; 15(3):153-9. PubMed ID: 15956900
[TBL] [Abstract][Full Text] [Related]
8. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
9. Comparing Observation, Axillary Radiotherapy, and Completion Axillary Lymph Node Dissection for Management of Axilla in Breast Cancer in Patients with Positive Sentinel Nodes: A Systematic Review.
Castelo M; Hu SY; Dossa F; Acuna SA; Scheer AS
Ann Surg Oncol; 2020 Aug; 27(8):2664-2676. PubMed ID: 32020394
[TBL] [Abstract][Full Text] [Related]
10. Does the result of completion axillary lymph node dissection influence the recommendation for adjuvant treatment in sentinel lymph node-positive patients?
Sávolt A; Polgár C; Musonda P; Mátrai Z; Rényi-Vámos F; Tóth L; Kásler M; Péley G
Clin Breast Cancer; 2013 Oct; 13(5):364-70. PubMed ID: 23773380
[TBL] [Abstract][Full Text] [Related]
11. [Mastoscopic axillary lymph node dissection for the patients with breast cancer].
Luo CY; Zhang J; Lin H; Yang Q; Huang X; Xue L; Zhang YZ; Li GH
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1946-8. PubMed ID: 14703427
[TBL] [Abstract][Full Text] [Related]
12. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
[TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98).
Agresti R; Martelli G; Sandri M; Tagliabue E; Carcangiu ML; Maugeri I; Pellitteri C; Ferraris C; Capri G; Moliterni A; Bianchi G; Mariani G; Trecate G; Lozza L; Langer M; Rampa M; Gennaro M; Greco M; Menard S; Pierotti MA
Cancer; 2014 Mar; 120(6):885-93. PubMed ID: 24323615
[TBL] [Abstract][Full Text] [Related]
14. Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node.
Houvenaeghel G; Cohen M; Raro P; De Troyer J; de Lara CT; Gimbergues P; Gauthier T; Faure-Virelizier C; Vaini-Cowen V; Lantheaume S; Regis C; Darai E; Ceccato V; D'Halluin G; Del Piano F; Villet R; Jouve E; Beedassy B; Theret P; Gabelle P; Zinzindohoue C; Opinel P; Marsollier-Ferrer C; Dhainaut-Speyer C; Colombo PE; Lambaudie E; Tallet A; Boher JM;
BMC Cancer; 2018 Nov; 18(1):1153. PubMed ID: 30463611
[TBL] [Abstract][Full Text] [Related]
15. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.
Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B
Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739
[TBL] [Abstract][Full Text] [Related]
16. Factors that determine whether a patient receives completion axillary lymph node dissection after a positive sentinel lymph node biopsy for breast cancer in British Columbia.
Aslani N; Swanson T; Kennecke H; Woods R; Davis N
Can J Surg; 2011 Aug; 54(4):237-42. PubMed ID: 21651836
[TBL] [Abstract][Full Text] [Related]
17. Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.
Poodt IGM; Spronk PER; Vugts G; van Dalen T; Peeters MTFDV; Rots ML; Kuijer A; Nieuwenhuijzen GAP; Schipper RJ
Ann Surg; 2018 Dec; 268(6):1084-1090. PubMed ID: 28742702
[TBL] [Abstract][Full Text] [Related]
18. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
[TBL] [Abstract][Full Text] [Related]
19. A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
Beek MA; Gobardhan PD; Klompenhouwer EG; Menke-Pluijmers MB; Steenvoorde P; Merkus JW; Rutten HJ; Voogd AC; Luiten EJ
Eur J Surg Oncol; 2020 Jan; 46(1):59-64. PubMed ID: 31402072
[TBL] [Abstract][Full Text] [Related]
20. Breast-conserving surgery without axillary lymph node surgery or radiotherapy is safe for HER2-positive and triple negative breast cancer patients over 70 years of age.
Zhong Y; Xu Y; Zhou Y; Mao F; Lin Y; Guan J; Shen S; Pan B; Wang C; Peng L; Huang X; Li Y; Wang X; Sun Q
Breast Cancer Res Treat; 2020 Jul; 182(1):117-126. PubMed ID: 32430680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
